Embla Medical hf. (CPH:EMBLA)
Denmark · Delayed Price · Currency is DKK 28.30
+0.10 (0.35%)
Jul 28, 2026, 4:59 PM CET
Embla Medical Market Cap
Embla Medical has a market cap or net worth of 12.05 billion as of July 28, 2026. Its market cap has decreased by -12.12% in one year.
Market Cap
12.05B
Enterprise Value
14.94B
Revenue
6.44B
Ranking
n/a
PE Ratio
19.75
Stock Price
28.30
ChartMarket Cap Chart
Since September 4, 2009, Embla Medical's market cap has increased from 2.33B to 12.05B, an increase of 418.06%. That is a compound annual growth rate of 10.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 12.05B | -13.22% |
| Dec 30, 2025 | 13.89B | -8.62% |
| Dec 30, 2024 | 15.20B | 31.74% |
| Dec 29, 2023 | 11.54B | -18.15% |
| Dec 30, 2022 | 14.10B | -21.07% |
| Dec 30, 2021 | 17.86B | -12.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.42T |
| Genmab | 115.33B |
| Coloplast | 90.88B |
| Demant | 57.70B |
| H. Lundbeck | 40.54B |
| Zealand Pharma | 20.52B |
| Ambu A/S | 17.98B |
| Bavarian Nordic | 13.32B |